Latest Angina pectoris Stories
New Insights, Discoveries and Interim Clinical Data on Generx® Phase 3 Angiogenic Therapy for Patients with Cardiac Microvascular Insufficiency and Coronary Artery Disease SAN DIEGO,
Announces Formation of Angionetics and Activation Therapeutics: New Operating Units to Facilitate the Independent Monetization and Funding of Generx® and Excellagen® SAN DIEGO, Nov.
Men and women suffering a heart attack go through very similar stages of pain, but their reactions are very different, and women will delay seeking care, putting their health at risk.
MarketOptimizer.org adds “Unstable Angina Global Clinical Trials Review, H2, 2014” to its store.
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill.,
Analysis From SHIFT Study Shows Ivabradine Reduced Cardiovascular Death or Hospitalization for Worsening Heart Failure Independent of Baseline Blood Pressure With Similar Safety Profile Across Groups THOUSAND
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time WASHINGTON, Sept.
U.S. hospitalizations and deaths from heart disease and stroke dropped significantly in the last decade, according to new research in the American Heart Association journal Circulation.
SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc.
EECP Treatment is FDA-Cleared for Refractory Angina and Offered at Dr.